Clinical Trials & Research Studies

This chart is a summary of all actively enrolling studies. To see detailed descriptions of condition-specific research studies and clinical trials, please visit these links:

Summer 2017 Newsletter

Research StudyEligibilityContact Person
Emory Alzheimer's Disease Research Center Honor Research Registry
Longitudinal study of changes in memory and other cognitive skills
  • Aging people with no memory problems
  • People of any age with MCI, Alzheimer's disease or other forms of dementia
  • Willing to participate in additional research studies
  • Study partner available to participate in visits
Erin Carter
erin.carter@emory.edu
404-712-6838
AbbVie
2-year infusion study
  • Diagnosis of MCI/AD
  • 55-85 years old
  • Caregiver availability
Rebekah Rogers
rebekah.d.rogers@emory.edu
404-712-4234
ADMET-2
Study to treat apathy in AD
  • Diagnosis of Alzheimer's disease
  • Study partner available for all visits
Tamara Attis
tattis@emory.edu
404-712-6914
ADNI-3
Alzheimer's Disease Neuroimaging Initiative
  • Age 55-90
  • Healthy controls/Diagnosis of MCI/AD
  • Study partner available for all visits
Becky Byram
rbyram@emory.edu
404-712-0195
Aerobic exercise and Cognitive Training in Older Adults
  • 65-89 years old
  • Cognitively normal
Holly Hudson
Holly.Hudson@va.gov
404-321-6111 ext 7099
AVID Autopsy
A 6-mth study to evaluate new MRI techniques
  • Diagnosis of Alzheimer's disease
  • Life expectancy of < 6 mths
Erin Carter
erin.carter@emory.edu
404-712-6838
BIOGEN-FTD
1 year observational study
  • Diagnosis of behavioral variant frontotemporal dementia (FTD)
  • Healthy subjects
  • 18 - 80 years of age
Tamara Attis
tattis@emory.edu
404-712-6914
Calibrex
1-year study of the relationship between high blood pressure and AD
  • Cognitively normal or MCI
  • 60 years of age or older
  • Hypertensive
Hina Ahmed
hina.ahmed@emory.edu
404-712-2036

Ihab Hajjar
ihabhajjar@emory.edu
CEDAR
1-year study on the effects of candesartan vs placebo in mild cognitive impairment and Alzheimer's disease
  • Subjective memory concerns
  • 50 years of age or older
  • Please contact study coordinator for other criteria
Maureen Okafor
m.o.okafor@emory.edu
404-712-2881

Ihab Hajjar
ihabhajjar@emory.edu
CREAD
A 2 year infusion study to slow Alzheimer's disease (AD) progression
  • Diagnosis of mild to moderate AD
  • 50-85 yrs old
  • Evidence of AD pathology
  • Study partner available for all visits
  • Willing to undergo PET scan or lumbar puncture
Phyllis Vaughn
pvaughn@emory.edu
404-712-6901
Daybreak
A 78-week study of a drug designed to slow Alzheimer┬┐s disease (AD) progression by lowering beta amyloid production
  • Diagnosis of mild cognitive impairment due to Alzheimer's disease
  • 55-85 yrs old
  • Must agree to undergo ApoE genotyping
  • Willing to undergo MRI & PET scans
Aaron Milloy
aaron.m.milloy@emory.edu
404-712-6855
EARLY
5-year prevention trial
  • Cognitively normal
  • 65-85 years old
  • Study partner available for all study visits
Deborah Westover
dwestov@emory.edu
404-712-6807
EMERGE
A 12-month infusion study to slow progression of cognitive and functional impairment
  • Diagnosis of mild cognitive impairment
  • 50-85 yrs old
  • Must agree to undergo ApoE genotyping
  • Study partner available for all visits
Michelle Wiles
mkwiles@emory.edu
404-778-0664
Emory Healthy Aging Study
Longitudinal study of aging
  • 18 years of age or older
  • Read and speak English fluently
Lauren Lewis
lauren.m.lewis@emory.edu
404-727-4877
Exercise and Motor Dexterity
  • greater than 60 years of age
  • Cognitively normal
Holly Hudson
Holly.Hudson@va.gov
404-321-6111 ext 7099
EXERT
Study of effects of aerobic exercise on cognition
  • Diagnosis of Mild Cognitive Impairment
  • 65-89 years of age
Tamara Attis
tattis@emory.edu
404-712-6914
Generation 2
5 - 7 year prevention trial for healthy participants
  • 60 - 75
  • Cognitively unimpaired
  • Study partner available for all visits
Erin Carter
erin.carter@emory.edu
404-712-6838
HEART
8-month study of an FDA-approved blood pressure medicine in the African-American population.
  • African-American
  • 45 years and older
  • Have or did have a parent with dementia
Danielle Verble
danielle.d.verble@emory.edu
404-712-7085
Memory and Aging in African Americans and Caucasians
  • Age 55 - 90 with no memory problems or MCI or mild Alzheimer's
  • Study partner available for all study visits
  • Willing to have imaging & lumbar puncture
William Hu
wthu@emory.edu
404-727-4174

Monica Parker
monica.willis.willis-parker@emory.edu
404-727-0648
NeuroVision
2-day study that involves imaging of the retina
  • Individuals with MCI or Alzheimer's disease, frontotemporal dementia, or cognitively normal
  • Over 50 years of age
CeeCee Manzanares
cmanzan@emory.edu
404-727-9324
SERENE
3-month study aimed at reducing agitation and aggression in Alzheimer's disease
  • Greater than 50 years of age
  • Diagnosis of probable Alzheimer's disease
  • Clinically significant agitation
  • Reliable caregiver/study partner
Becky Byram
rbyram@emory.edu
404-712-0195
Tau Imaging (GN30009)
18-month observational imaging study
  • Diagnosis of prodromal, mild or moderate Alzheimer┬┐s disease
  • 50 - 80 years old
  • Study partner available for all study visits
Deborah Westover
dwestov@emory.edu
404-712-6807
TRIAD
A 4-month study aimed at reducing agitation in Alzheimer's disease
  • Diagnosis of Alzheimer's disease
  • 50 - 90 years of age
  • Clinically significant agitation
  • Reliable caregiver
Andrea Kippels
ajkippe@emory.edu
404-712-6868
VASCULAR
2-year observational study of the relationship between vascular factors and memory loss
  • Cognitively normal or MCI
  • 50 years of age or older
Tiffany Thomas
tlthom@emory.edu
404-712-3639

Ihab Hajjar
ihabhajjar@emory.edu